Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen-Reference-Cited by-同舟云学术

Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen

Published:2009-06 Issue:6 Volume:82 Page:433-439
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Berenson James R.,Yellin Ori,Woytowitz Donald,Flam Marshall S.,Cartmell Alan,Patel Ravi,Duvivier Herb,Nassir Youram,Eades Benjamin,Abaya Christina DiLauro,Hilger Jacqueline,Swift Regina A.

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2009.01244.x/fullpdf

Reference33 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med,1996

3. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

4. High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA;Bladé;Blood,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitamin C Supplementation in the Treatment of Autoimmune and Onco-Hematological Diseases: From Prophylaxis to Adjuvant Therapy;International Journal of Molecular Sciences;2024-07-02

2. Effect of vitamins C and E on cancer survival; a systematic review;DARU Journal of Pharmaceutical Sciences;2022-09-22

3. Diverse antitumor effects of ascorbic acid on cancer cells and the tumor microenvironment;Frontiers in Oncology;2022-09-20

4. Pharmacological dose ascorbic acid administration in relapsed refractory multiple myeloma patients;Leukemia Research Reports;2021

5. Vitamin C and cancer risk and treatment;Postępy Higieny i Medycyny Doświadczalnej;2021-01-01